2型糖尿病患者血清白介素10与颈动脉粥样硬化的相关性研究

被引:7
作者
张晓蕾
韩玲玲
尚小菁
机构
[1] 中国医科大学附属第四医院内分泌科
关键词
糖尿病,2型; 白细胞介素10; 动脉粥样硬化; 相关性;
D O I
暂无
中图分类号
R587.1 [糖尿病]; R543.4 [颈动、静脉疾病];
学科分类号
100201 [内科学];
摘要
目的探讨2型糖尿病(T2DM)患者血清白介素10(IL-10)与颈动脉粥样硬化的关系。方法选取2013年1—6月中国医科大学附属第四医院内分泌科收治住院的T2DM患者292例。按颈动脉内膜中层厚度(IMT)分为IMT正常组(IMT≤1.0 mm)98例、IMT增厚组(1.0 mm<IMT≤1.3 mm)101例及颈动脉粥样硬化斑块形成组(IMT>1.3 mm)93例,另选取该院体检中心体检健康者100例作为对照组。均测定血清IL-10、空腹血糖、糖化血红蛋白和IMT。结果 4组的颈动脉IMT、血清IL-10、空腹血糖、糖化血红蛋白比较,差异均有统计学意义(P<0.05)。IMT正常组、IMT增厚组、颈动脉粥样硬化斑块形成组的颈动脉IMT、空腹血糖、糖化血红蛋白均高于对照组(P<0.05);且颈动脉粥样硬化斑块形成组的空腹血糖、糖化血红蛋白高于IMT正常组(P<0.05)。IMT增厚组、颈动脉粥样硬化斑块形成组的血清IL-10低于对照组和IMT正常组(P<0.05);而IMT正常组血清IL-10与对照组比较,差异无统计学意义(P>0.05)。颈动脉IMT与血清IL-10呈负相关(r=-0.57,P<0.05);而与空腹血糖及糖化血红蛋白无直线相关性(r=-0.39、-0.42,P=0.062、0.057)。结论 T2DM患者血清IL-10与颈动脉IMT呈负相关,对颈动脉粥样硬化斑块的形成可能具有保护作用,为临床进一步研究提供了有益的参考价值。
引用
收藏
页码:3502 / 3504
页数:3
相关论文
共 17 条
[1]
内科学.[M].叶任高等主编.人民卫生出版社.2004,
[2]
内科学.[M].叶任高等; 编著.人民卫生出版社.2004,
[3]
Prevalence of Diabetes among Men and Women in China [J].
Yang, Wenying ;
Lu, Juming ;
Weng, Jianping ;
Jia, Weiping ;
Ji, Linong ;
Xiao, Jianzhong ;
Shan, Zhongyan ;
Liu, Jie ;
Tian, Haoming ;
Ji, Qiuhe ;
Zhu, Dalong ;
Ge, Jiapu ;
Lin, Lixiang ;
Chen, Li ;
Guo, Xiaohui ;
Zhao, Zhigang ;
Li, Qiang ;
Zhou, Zhiguang ;
Shan, Guangliang ;
He, Jiang .
NEW ENGLAND JOURNAL OF MEDICINE, 2010, 362 (12) :1090-1101
[4]
IL-10-induced TNF-alpha mRNA destabilization is mediated via IL-10 suppression of p38 MAP kinase activation and inhibition of HuR expression [J].
Rajasingh, Johnson ;
Bord, Evelyn ;
Luedemann, Corinne ;
Asai, Jun ;
Hamada, Hiromichi ;
Thorne, Tina ;
Qin, Gangjian ;
Goukassian, David ;
Zhu, Yan ;
Losordo, Douglas W. ;
Kishore, Raj .
FASEB JOURNAL, 2006, 20 (12) :2112-+
[5]
Interleukin-10 expression is positively correlated with oxidized LDL deposition and inversely with T-lymphocyte infiltration in atherosclerotic intimas of human coronary arteries [J].
Sumiyoshi, S ;
Nakashima, Y ;
Chen, YX ;
Itabe, H ;
Sueishi, K .
PATHOLOGY RESEARCH AND PRACTICE, 2006, 202 (03) :141-150
[6]
Type 2 diabetes as an inflammatory cardiovascular disorder [J].
Ziegler, D .
CURRENT MOLECULAR MEDICINE, 2005, 5 (03) :309-322
[7]
Hypertension and subclinical carotid atherosclerosis in a suburban general population in China [J].
Lu, M ;
Wu, LX ;
Shi, P ;
Kang, S ;
Shi, LJ ;
Wu, YF .
JOURNAL OF HYPERTENSION, 2004, 22 (09) :1699-1706
[8]
Overexpression of interleukin-10 by activated T lymphocytes inhibits atherosclerosis in LDL receptor-deficient mice by altering lymphocyte and macrophage phenotypes [J].
Pinderski, LJ ;
Fischbein, MP ;
Subbanagounder, G ;
Fishbein, MC ;
Kubo, N ;
Cheroutre, H ;
Curtiss, LK ;
Berliner, JA ;
Boisvert, WA .
CIRCULATION RESEARCH, 2002, 90 (10) :1064-1071
[9]
Attenuation of atherogenesis by systemic and local adenovirus-mediated gene transfer of interleukin-10 in LDLr-/- mice..[J].Von Der Thüsen J H;Kuiper J;Fekkes M L;De Vos P;Van Berkel T J;Biessen E A.FASEB journal : official publication of the Federation of American Societies for Experimental Biology.2001, 14
[10]
Protective role of interleukin-10 in atherosclerosis [J].
Mallat, Z ;
Besnard, S ;
Duriez, M ;
Deleuze, V ;
Emmanuel, F ;
Bureau, MF ;
Soubrier, F ;
Esposito, B ;
Duez, H ;
Fievet, C ;
Staels, B ;
Duverger, N ;
Scherman, D ;
Tedgui, A .
CIRCULATION RESEARCH, 1999, 85 (08) :E17-E24